Tuesday, May 30, 2017

Brief Blog: Incredible Concert Genetics Reports on Genomics Industry and BRCA Industry

Concert Genetics (formerly NextDxGx) is a company that provides services to health plans nationally to help them manage genetic testing.  Home page here.

A Wall Street report on the genomics industry this week cites several deep-dive PDF-format studies available from Concert Genetics (download with simple email registration).

These include:
  • "The Current Landscape of Genetic Testing" - 20 pp, here.
  • "A Guide to BRCA Testing for Health Plans" - 12 pp, here.
  • "Critical Steps to Realizing the Potential of Personalized Medicine" - 24 pp, here.
Many interesting graphics, charts, and tables.


For a publicly available checklist of process management for an out of network molecular lab, see here.
Publicly available sources suggest Concerto (NextGxDx) has raised about $10M in venture capital, here.